Shares of Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF – Get Free Report) dropped 9.4% on Thursday . The stock traded as low as $14.95 and last traded at $14.95. Approximately 1,250 shares changed hands during mid-day trading, a decline of 7% from the average daily volume of 1,350 shares. The stock had previously closed at $16.50.
Kyowa Kirin Trading Down 9.4%
The stock’s fifty day moving average is $15.61 and its two-hundred day moving average is $14.85.
About Kyowa Kirin
Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.
Featured Articles
- Five stocks we like better than Kyowa Kirin
- What is the FTSE 100 index?
- Astera Labs: AI Infrastructure Play With Significant Growth Ahead
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Is IBM’s AI Transformation Powering a Sustained Rally?
- What Are the U.K. Market Holidays? How to Invest and Trade
- NVIDIA’s Stock Price Hits New Highs: This Is What’s Next
Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with MarketBeat.com's FREE daily email newsletter.
